Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Cisplatin × Clear all

NCT07276360 2026-03-27

HypoRTCx-UG

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT06535607 2026-03-24

eVOLVE-02

Phase 2 Recruiting

GastrointestinalGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Uterine Cervical Neoplasms

NCT00421096 2026-03-13

GEMCOL

Phase 2 Terminated

Uterine Cervical Neoplasms

NCT05521997 2026-03-13

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT06331468 2025-12-26

Hypofractionated Radiochemotherapy

Phase 2 Recruiting

Uterine Cervical Neoplasms, Uterine Neoplasms

NCT07232654 2025-12-01

Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT00957411 2025-11-24

CETUXICOL

Phase 2 Completed

Uterine Cervical Neoplasms

NCT07244965 2025-11-24

Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT07088731 2025-09-22

Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT05007106 2025-08-14

KEYVIBE-005

Phase 2 Completed

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT03086681 2025-07-29

ECWHCCFLACC

Phase 2 Completed

Uterine Cervical Neoplasms

NCT02635360 2025-07-03

Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer

Phase 2 Completed

94 enrolled 16 charts

Uterine Cervical Neoplasms

NCT03255252 2025-05-18

IMMUVIX

Phase 2 Terminated

Uterine Cervical Neoplasms

NCT06942416 2025-04-24

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

NCT03527264 2025-04-04

BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer

Phase 2 Terminated

4 enrolled 11 charts

Uterine Cervical Neoplasms

NCT06786780 2025-03-26

ECCO

Phase 2 Enrolling by invitation

Uterine Cervical Neoplasms

NCT06288360 2025-03-20

Neoadjuvant Immunochemotherapy in PD-L1-negative LACC

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT04868708 2025-03-04

A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer

Phase 2 Completed

Diabetes Mellitus, Insulin-Dependent, 12, Uterine Cervical Neoplasms, Recurrence

NCT04275713 2025-01-20

METOXY-LACC

Phase 2 Completed

Uterine Cervical Neoplasms

NCT06289062 2024-11-05

Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT06289751 2024-09-19

Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT03367871 2024-06-18

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Phase 2 Terminated

17 enrolled 12 charts

Uterine Cervical Neoplasms

NCT06426056 2024-05-23

Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT06419673 2024-05-17

Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer

Phase 2 Active not recruiting

Uterine Cervical Neoplasms

NCT05910177 2024-03-06

Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin

Phase 2 Recruiting

Carcinoma, Uterine Cervical Neoplasms

NCT05588219 2023-11-24

Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT05998941 2023-11-22

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT05799469 2023-04-05

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT01590017 2022-07-27

Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer

Phase 2 Completed

41 enrolled 10 charts

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms, HIV Infections

NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Phase 2 Withdrawn

Uterine Cervical Neoplasms, HIV Infections

NCT05105672 2021-12-28

A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT05151549 2021-12-09

A Study of Carilizumab Combined With Concurrent Chemoradiotherapy

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT04974944 2021-10-01

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT04974827 2021-08-10

A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT04973904 2021-07-22

Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT02394652 2021-04-21

The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial

Phase 2 Completed

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT01019278 2020-04-03

Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT02880007 2020-03-10

TRIDICOL

Phase 2 Completed

Uterine Cervical Neoplasms

NCT04121975 2019-10-10

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT03912402 2019-05-09

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT00331760 2019-02-26

Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery

Phase 2 Completed

106 enrolled 14 charts

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT00257829 2018-12-03

Improving Tumor Oxygenation in Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT03469531 2018-08-13

Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Neoplasms

NCT00369122 2018-03-20

Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer

Phase 2 Completed

60 enrolled 8 charts

Uterine Cervical Neoplasms

NCT00257816 2018-02-05

Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00691301 2018-01-09

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Phase 2 Completed

55 enrolled 10 charts

Uterine Cervical Neoplasms

NCT01276730 2017-12-29

Advanced Cervical Cancer Trial in India

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00941070 2017-11-17

Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer

Phase 2 Completed

26 enrolled 23 charts

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT02432365 2017-10-30

Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT00590967 2016-08-29

A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy

Phase 2 Terminated

69 enrolled 6 charts

Uterine Cervical Neoplasms